Nanoparticles Purification and Single-Particle Characterization from Bench to Clinical Insights: SEE and Izon Science at AICC 2026

November 4–6, 2026 | University of Calabria, Rende, Italy

How can advances in nanoparticle purification and characterization help bridge the gap between laboratory research and clinically relevant applications?

This question will be at the heart of Izon Science's contribution to the 38th AICC International Meeting – “Precision Medicine in the Big Data Age”, taking place from November 4 to 6, 2026, at the University of Calabria in Rende, Italy.

SEE Srl will attend the congress alongside its partner Izon Science, contributing to the discussion on technologies that support the transition from experimental research to scalable and reproducible workflows.

From Bench to Clinically Relevant Insights

As extracellular vesicles (EVs) and other biological nanoparticles gain increasing attention in biomarker discovery, disease research, and precision medicine, the need for reliable purification and characterization methods becomes increasingly important.

At AICC 2026, Caterina Severi from Izon Science will deliver a presentation entitled: “From Bench to Clinically Relevant Insights: Scaled-Up Nanoparticles Purification and Single-Particle Characterization”

The presentation will explore a topic central to modern nanoparticle research: the importance of scaling up purification processes while maintaining the ability to characterize individual particles.

These challenges are particularly relevant for laboratories moving beyond small-scale experiments towards more demanding research applications.